<?xml version="1.0" encoding="UTF-8"?>
<!-- XBRL document created with Ez-XBRL version 6.0.0.1 [06/29/2012 01:37:11 PM] -->
<!-- Based on XBRL 2.1 -->
<xbrli:xbrl xmlns:cjjd="http://www.chinajojodrugstores.com/20120331" xmlns:us-gaap="http://fasb.org/us-gaap/2012-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:currency="http://xbrl.sec.gov/currency/2012-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2012-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:invest="http://xbrl.sec.gov/invest/2012-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:country="http://xbrl.sec.gov/country/2012-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2012-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="cjjd-20120331.xsd" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
  <xbrli:context id="Context_FYE_31-Mar-2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-04-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-04-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-04-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_RetainedEarningsUnappropriatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsUnappropriatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-04-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2010-04-01</xbrli:startDate>
      <xbrli:endDate>2011-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2011">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_FYE_31-Mar-2012">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-04-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-04-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-04-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_RetainedEarningsUnappropriatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsUnappropriatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-04-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-04-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-04-01</xbrli:startDate>
      <xbrli:endDate>2012-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2012">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_22-Jun-2012">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-06-22</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2010">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_RetainedEarningsAppropriatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsAppropriatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_RetainedEarningsUnappropriatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsUnappropriatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2010-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_RetainedEarningsAppropriatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsAppropriatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_RetainedEarningsAppropriatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsAppropriatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_RetainedEarningsUnappropriatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsUnappropriatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_RetainedEarningsUnappropriatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsUnappropriatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_NoncontrollingInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001413263</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USD_per_Share">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <dei:EntityRegistrantName contextRef="Context_FYE_31-Mar-2012">CHINA JO-JO DRUGSTORES, INC.</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey contextRef="Context_FYE_31-Mar-2012">0001413263</dei:EntityCentralIndexKey>
  <dei:TradingSymbol contextRef="Context_FYE_31-Mar-2012">cjjd</dei:TradingSymbol>
  <dei:EntityCurrentReportingStatus contextRef="Context_FYE_31-Mar-2012">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityVoluntaryFilers contextRef="Context_FYE_31-Mar-2012">No</dei:EntityVoluntaryFilers>
  <dei:CurrentFiscalYearEndDate contextRef="Context_FYE_31-Mar-2012">--03-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityFilerCategory contextRef="Context_FYE_31-Mar-2012">Smaller Reporting Company</dei:EntityFilerCategory>
  <dei:EntityCommonStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_22-Jun-2012" unitRef="shares">13571553</dei:EntityCommonStockSharesOutstanding>
  <dei:DocumentType contextRef="Context_FYE_31-Mar-2012">10-K</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="Context_FYE_31-Mar-2012">2012-03-31</dei:DocumentPeriodEndDate>
  <dei:AmendmentFlag contextRef="Context_FYE_31-Mar-2012">false</dei:AmendmentFlag>
  <dei:DocumentFiscalYearFocus contextRef="Context_FYE_31-Mar-2012">2012</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="Context_FYE_31-Mar-2012">FY</dei:DocumentFiscalPeriodFocus>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">6489905</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">3833216</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue decimals="0" contextRef="Context_As_Of_31-Mar-2010" unitRef="USD">801593</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">921876</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">2818449</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:AccountsReceivableNetCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">1484850</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">16516671</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:InventoryNet decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">4617420</us-gaap:InventoryNet>
  <us-gaap:InventoryNet decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">6875574</us-gaap:InventoryNet>
  <us-gaap:OtherReceivablesNetCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">1049564</us-gaap:OtherReceivablesNetCurrent>
  <us-gaap:OtherReceivablesNetCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">603294</us-gaap:OtherReceivablesNetCurrent>
  <us-gaap:AdvancesOnInventoryPurchases decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">16528772</us-gaap:AdvancesOnInventoryPurchases>
  <us-gaap:AdvancesOnInventoryPurchases decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">14347557</us-gaap:AdvancesOnInventoryPurchases>
  <us-gaap:OtherAssetsCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">8364267</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherAssetsCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">2853301</us-gaap:OtherAssetsCurrent>
  <us-gaap:AssetsCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">39456654</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">47848062</us-gaap:AssetsCurrent>
  <us-gaap:PropertyPlantAndEquipmentNet decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">5471432</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">15647120</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:DepositsAssetsNoncurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">2540758</us-gaap:DepositsAssetsNoncurrent>
  <us-gaap:DepositsAssetsNoncurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">2872219</us-gaap:DepositsAssetsNoncurrent>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">390302</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">2816945</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:OtherAssetsNoncurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">9006538</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">11465831</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:Assets decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">53934624</us-gaap:Assets>
  <us-gaap:Assets decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">74961013</us-gaap:Assets>
  <us-gaap:AccountsPayableTradeCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">3530204</us-gaap:AccountsPayableTradeCurrent>
  <us-gaap:AccountsPayableTradeCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">13906383</us-gaap:AccountsPayableTradeCurrent>
  <us-gaap:NotesPayableCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">2704680</us-gaap:NotesPayableCurrent>
  <us-gaap:NotesPayableCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">4208928</us-gaap:NotesPayableCurrent>
  <us-gaap:AccountsPayableOtherCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">627734</us-gaap:AccountsPayableOtherCurrent>
  <us-gaap:AccountsPayableOtherCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">782586</us-gaap:AccountsPayableOtherCurrent>
  <us-gaap:DueToOfficersOrStockholdersCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">880058</us-gaap:DueToOfficersOrStockholdersCurrent>
  <us-gaap:DueToOfficersOrStockholdersCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">1458441</us-gaap:DueToOfficersOrStockholdersCurrent>
  <us-gaap:CustomerDepositsCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">2038608</us-gaap:CustomerDepositsCurrent>
  <us-gaap:CustomerDepositsCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">1332141</us-gaap:CustomerDepositsCurrent>
  <us-gaap:TaxesPayableCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">1624558</us-gaap:TaxesPayableCurrent>
  <us-gaap:TaxesPayableCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">469606</us-gaap:TaxesPayableCurrent>
  <us-gaap:AccruedLiabilitiesCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">311639</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">417184</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">11717481</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">22575269</us-gaap:LiabilitiesCurrent>
  <us-gaap:DerivativeLiabilitiesNoncurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">153226</us-gaap:DerivativeLiabilitiesNoncurrent>
  <us-gaap:DerivativeLiabilitiesNoncurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">34419</us-gaap:DerivativeLiabilitiesNoncurrent>
  <us-gaap:Liabilities decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">11870707</us-gaap:Liabilities>
  <us-gaap:Liabilities decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">22609688</us-gaap:Liabilities>
  <us-gaap:CommitmentsAndContingencies xsi:nil="true" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD"/>
  <us-gaap:CommitmentsAndContingencies xsi:nil="true" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD"/>
  <us-gaap:PreferredStockValue xsi:nil="true" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD"/>
  <us-gaap:PreferredStockValue xsi:nil="true" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD"/>
  <us-gaap:CommonStockValue decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">13530</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">13589</us-gaap:CommonStockValue>
  <us-gaap:AdditionalPaidInCapitalCommonStock decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">16333956</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">16853039</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:RetainedEarningsAppropriated decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">1309109</us-gaap:RetainedEarningsAppropriated>
  <us-gaap:RetainedEarningsAppropriated decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">1309109</us-gaap:RetainedEarningsAppropriated>
  <us-gaap:RetainedEarningsUnappropriated decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">23287474</us-gaap:RetainedEarningsUnappropriated>
  <us-gaap:RetainedEarningsUnappropriated decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">31429100</us-gaap:RetainedEarningsUnappropriated>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">1119848</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">2747561</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">42063917</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">52351325</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2010" unitRef="USD">16689749</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">10000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">877884</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_RetainedEarningsAppropriatedMember" unitRef="USD">1309109</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_RetainedEarningsUnappropriatedMember" unitRef="USD">14855016</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">-362260</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity xsi:nil="true" contextRef="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD"/>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">13530</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">13589</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">16333956</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">16853039</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_RetainedEarningsAppropriatedMember" unitRef="USD">1309109</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_RetainedEarningsAppropriatedMember" unitRef="USD">1309109</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_RetainedEarningsUnappropriatedMember" unitRef="USD">23287474</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_RetainedEarningsUnappropriatedMember" unitRef="USD">31429100</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">1119848</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">2747561</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity xsi:nil="true" contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD"/>
  <us-gaap:StockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">-1073</us-gaap:StockholdersEquity>
  <us-gaap:MinorityInterest decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">-1073</us-gaap:MinorityInterest>
  <us-gaap:LiabilitiesAndStockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">53934624</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">74961013</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">42063917</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">52352398</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:PreferredStockParOrStatedValuePerShare decimals="3" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD_per_Share">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare decimals="3" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD_per_Share">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized decimals="INF" contextRef="Context_As_Of_31-Mar-2011" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized decimals="INF" contextRef="Context_As_Of_31-Mar-2012" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued xsi:nil="true" contextRef="Context_As_Of_31-Mar-2011" unitRef="shares"/>
  <us-gaap:PreferredStockSharesIssued xsi:nil="true" contextRef="Context_As_Of_31-Mar-2012" unitRef="shares"/>
  <us-gaap:PreferredStockSharesOutstanding xsi:nil="true" contextRef="Context_As_Of_31-Mar-2011" unitRef="shares"/>
  <us-gaap:PreferredStockSharesOutstanding xsi:nil="true" contextRef="Context_As_Of_31-Mar-2012" unitRef="shares"/>
  <us-gaap:CommonStockParOrStatedValuePerShare decimals="3" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD_per_Share">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare decimals="3" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD_per_Share">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized decimals="INF" contextRef="Context_As_Of_31-Mar-2011" unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized decimals="INF" contextRef="Context_As_Of_31-Mar-2012" unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued decimals="INF" contextRef="Context_As_Of_31-Mar-2011" unitRef="shares">13530477</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued decimals="INF" contextRef="Context_As_Of_31-Mar-2012" unitRef="shares">13589621</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_31-Mar-2011" unitRef="shares">13530477</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_31-Mar-2012" unitRef="shares">13589621</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_31-Mar-2010_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares">10000000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares">13530477</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding decimals="INF" contextRef="Context_As_Of_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares">13589621</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:SalesRevenueNet decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">69969479</us-gaap:SalesRevenueNet>
  <us-gaap:SalesRevenueNet decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">94352885</us-gaap:SalesRevenueNet>
  <us-gaap:CostOfGoodsAndServicesSold decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">48827385</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:CostOfGoodsAndServicesSold decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">66790084</us-gaap:CostOfGoodsAndServicesSold>
  <us-gaap:GrossProfit decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">21142094</us-gaap:GrossProfit>
  <us-gaap:GrossProfit decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">27562801</us-gaap:GrossProfit>
  <us-gaap:SellingExpense decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">4838745</us-gaap:SellingExpense>
  <us-gaap:SellingExpense decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">8498240</us-gaap:SellingExpense>
  <us-gaap:GeneralAndAdministrativeExpense decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">4723943</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">8582389</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:OperatingExpenses decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">9562688</us-gaap:OperatingExpenses>
  <us-gaap:OperatingExpenses decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">17080629</us-gaap:OperatingExpenses>
  <us-gaap:OperatingIncomeLoss decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">11579406</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">10482172</us-gaap:OperatingIncomeLoss>
  <us-gaap:OtherNonoperatingIncomeExpense decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">127172</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherNonoperatingIncomeExpense decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">187865</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">249225</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">118807</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">11955803</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">10788844</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
  <us-gaap:IncomeTaxExpenseBenefit decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">3523345</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:IncomeTaxExpenseBenefit decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">2648365</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-1147</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>

  <us-gaap:ProfitLoss decimals="0" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_RetainedEarningsUnappropriatedMember" unitRef="USD">8432458</us-gaap:ProfitLoss>


  <us-gaap:ProfitLoss decimals="0" contextRef="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_RetainedEarningsUnappropriatedMember" unitRef="USD">8141626</us-gaap:ProfitLoss>

  <us-gaap:ProfitLoss decimals="0" contextRef="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">-1147</us-gaap:ProfitLoss>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">1482108</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals="0" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">1482108</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">1627728</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals="0" contextRef="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD">1627713</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax decimals="0" contextRef="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">15</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">9914566</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">9769354</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="shares">13254792</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="shares">13568481</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="shares">13254792</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="shares">13569995</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:EarningsPerShareBasic decimals="2" contextRef="Context_FYE_31-Mar-2011" unitRef="USD_per_Share">0.64</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareBasic decimals="2" contextRef="Context_FYE_31-Mar-2012" unitRef="USD_per_Share">0.60</us-gaap:EarningsPerShareBasic>
  <us-gaap:EarningsPerShareDiluted decimals="2" contextRef="Context_FYE_31-Mar-2011" unitRef="USD_per_Share">0.64</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareDiluted decimals="2" contextRef="Context_FYE_31-Mar-2012" unitRef="USD_per_Share">0.60</us-gaap:EarningsPerShareDiluted>
  <us-gaap:DepreciationDepletionAndAmortization decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">810374</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">2340865</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:ShareBasedCompensation decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">153445</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">119052</us-gaap:ShareBasedCompensation>
  <us-gaap:ProvisionForDoubtfulAccounts decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">1669864</us-gaap:ProvisionForDoubtfulAccounts>
  <us-gaap:IncreaseDecreaseInAccountsReceivable decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">201405</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">14179193</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInInventories decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">648785</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:IncreaseDecreaseInInventories decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-2018848</us-gaap:IncreaseDecreaseInInventories>
  <us-gaap:IncreaseDecreaseInOtherReceivables decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">686305</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInOtherReceivables decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">372660</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInMaterialsAndSupplies decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">9177936</us-gaap:IncreaseDecreaseInMaterialsAndSupplies>
  <us-gaap:IncreaseDecreaseInMaterialsAndSupplies decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-2132100</us-gaap:IncreaseDecreaseInMaterialsAndSupplies>
  <us-gaap:IncreaseDecreaseInOtherCurrentAssets decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">6927371</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
  <us-gaap:IncreaseDecreaseInOtherCurrentAssets decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-5860584</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">131302</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInDepositOtherAssets decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">238630</us-gaap:IncreaseDecreaseInDepositOtherAssets>
  <us-gaap:IncreaseDecreaseInAccountsPayableTrade decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">1075811</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
  <us-gaap:IncreaseDecreaseInAccountsPayableTrade decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">15792680</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">2370213</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-1626827</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInCustomerDeposits decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-768651</us-gaap:IncreaseDecreaseInCustomerDeposits>
  <us-gaap:IncreaseDecreaseInAccruedTaxesPayable decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">329251</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
  <us-gaap:IncreaseDecreaseInAccruedTaxesPayable decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-1153346</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">-5183748</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">19967243</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">443112</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">4915241</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">606800</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">3308158</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">-5250092</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-14862667</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">-141192</us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities>
  <us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-1840419</us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities>
  <us-gaap:RepaymentsOfNotesPayable decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">-1152597</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:RepaymentsOfNotesPayable decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">7077596</us-gaap:RepaymentsOfNotesPayable>
  <us-gaap:ProceedsFromIssuanceOfCommonStock decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">15708608</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromShortTermDebt decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">-894564</us-gaap:ProceedsFromShortTermDebt>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">15770507</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-7934286</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">351645</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations>
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">173021</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">5688312</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-2656689</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:InterestPaid decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">23872</us-gaap:InterestPaid>
  <us-gaap:IncomeTaxesPaid decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">2235386</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxesPaid decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">4113553</us-gaap:IncomeTaxesPaid>
  <cjjd:NotesPayableTransferredToAccountsPayableVendors decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">5554131</cjjd:NotesPayableTransferredToAccountsPayableVendors>
  <cjjd:NotesPayableTransferredToAccountsPayableVendors decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">8468458</cjjd:NotesPayableTransferredToAccountsPayableVendors>
  <cjjd:DescriptionOfBusinessAndOrganizationTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"&gt;Note 1 &amp;#8211; DESCRIPTION OF BUSINESS AND ORGANIZATION&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;China Jo-Jo Drugstores, Inc. (&amp;#8220;Jo-Jo Drugstores&amp;#8221; or the &amp;#8220;Company&amp;#8221;), was incorporated in Nevada on December 19, 2006, originally under the name &amp;#8220;Kerrisdale Mining Corporation.&amp;#8221; On September 24, 2009, the Company changed its name to &amp;#8220;China Jo-Jo Drugstores, Inc.&amp;#8221; in connection with a share exchange transaction as described below.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;On September 17, 2009, the Company completed a share exchange transaction with Renovation Investment (Hong Kong) Co., Ltd. (&amp;#8220;Renovation&amp;#8221;), where by 7,900,000 shares of common stock were issued to the stockholders of Renovation in exchange for 100% of the capital stock of Renovation. The completion of the share exchange transaction resulted in a change of control. The share exchange transaction was accounted for as a reverse acquisition and recapitalization and, as a result, the consolidated financial statements of the Company (the legal acquirer) is, in substance, those of Renovation (the accounting acquirer), with the assets and liabilities, and revenues and expenses, of the Company being included effective from the date of the share exchange transaction. Renovation has no substantive operations of its own except for its holdings of Zhejiang Jiuxin Investment Management Co., Ltd. (&amp;#8220;Jiuxin Management&amp;#8221;), Zhejiang Shouantang Medical Technology Co., Ltd. (&amp;#8220;Shouantang Technology&amp;#8221;) and Hangzhou Jiutong Medical Technology Co., Ltd (&amp;#8220;Jiutong Medical&amp;#8221;), its wholly-owned subsidiaries.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;
&lt;div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; text-align: justify;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;The Company is a retail and wholesale distributor of pharmaceutical and other healthcare products in the People&amp;#8217;s Republic of China (&amp;#8220;China&amp;#8221; or the &amp;#8220;PRC&amp;#8221;). The Company&amp;#8217;s retail business is comprised primarily of pharmacies, a majority of which are operated by Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd. (&amp;#8220;Jiuzhou Pharmacy&amp;#8221;), a company&amp;#160;that the Company controls through contractual arrangements.&amp;#160;&amp;#160;Shanghai Lydia Grand Pharmacy Co., Ltd. (&amp;#8220;Shanghai Lydia&amp;#8221;), a wholly-owned subsidiary of Jiuzhou Pharmacy, operates two store locations in Shanghai. On July 29, 2011, Shanghai Lydia obtained control of Shanghai Bieyanghong Zhongxing Grand Pharmacy Co. Ltd. (&amp;#8220;Bieyanghong Zhongxing&amp;#8221;), which also operates one pharmacy in Shanghai (see Note 16 &amp;#8211; Business Combination), and Bieyanghong Zhongxing subsequently changed its name to Shanghai Lydia Zhongxing Grand Pharmacy Co., Ltd. (&amp;#8220;Shanghai Zhongxing&amp;#8221;). One drugstore is operated by Hangzhou Quannuo Grand Pharmacy Co., Ltd. (&amp;#8220;Hangzhou Quannuo&amp;#8221;), a wholly-owned subsidiary of Zhejiang Quannuo Internet Technology Co., Ltd. (&amp;#8220;Quannuo Technology&amp;#8221;), which is wholly-owned by Shouantang Technology.&amp;#160;&amp;#160;Four drugstores are operated by Zhejiang Jiuying Grand Pharmacy Co., Ltd. (&amp;#8220;Jiuying Pharmacy&amp;#8221;).&amp;#160;&amp;#160;39% and 10% of the equity interests of Jiuying Pharmacy are held by Shouantang Technology and Jiuxin Management, respectively, with the remaining 51% held by the three owners of Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service (the &amp;#8220;Owners&amp;#8221;).&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt; text-align: justify;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;br  /&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; text-align: justify;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;The Company&amp;#8217;s retail business also includes two medical clinics through Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine (&amp;#8220;Jiuzhou Clinic&amp;#8221;) and Hangzhou Jiuzhou Medical and Public Health Service Co., Ltd. (&amp;#8220;Jiuzhou Service&amp;#8221;), both of which are also controlled by the Company through contractual arrangements.&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt; text-align: justify;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;br  /&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; text-align: justify;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;The Company&amp;#8217;s wholesale business is primarily conducted through Zhejiang Jiuxin Medicine Co., Ltd. (&amp;#8220;Jiuxin Medicine&amp;#8221;), which is licensed to distribute prescription and non-prescription pharmaceutical products throughout China.&amp;#160;&amp;#160;Jiuzhou Pharmacy acquired Jiuxin Medicine on August 25, 2011 (See Note 16 &amp;#8211; Business Combination). &lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;The wholesale business also includes Hangzhou Qianhong Agriculture Development Co., Ltd. (&amp;#8220;Qianhong Agriculture&amp;#8221;), a wholly-owned subsidiary of Jiuxin Management, which operates a cultivation project of herbal plants used for traditional Chinese medicine (&amp;#8220;TCM&amp;#8221;), Tonglu Lydia Agriculture Development Co., Ltd. (&amp;#8220;Tonglu Lydia&amp;#8221;), a wholly-owned subsidiary of Shouantang Technology, which will do the same in the future, and Jiutong Medical, which processes the herbal plants, mainly cultivated by Qianhong Agriculture.&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div id="pgbrk" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;
&lt;div id="ftr"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;The accompanying consolidated financial statements reflect the activities of the Company and each of the following entities:&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" width="14%"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Entity Name&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-indent: 18pt; border-bottom: black 2px solid;" valign="bottom" width="2%" colspan="2"&gt;
&lt;div style="display: block; text-indent: 27pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Background&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-indent: 18pt; border-bottom: black 2px solid;" valign="bottom" width="2%" colspan="2"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Ownership&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Renovation&amp;#160;HK&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="margin-left: 0pt; text-indent: 9pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="tab2" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Incorporated in Hong Kong SAR on September 2, 2008&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;100%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Jiuxin&amp;#160;Management&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="margin-left: 0pt; text-indent: 9pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="margin-left: 54pt; text-indent: -45pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="ace3020a8-0da0-40ac-bd1c-d2925cf5e2f8" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Established in the PRC on October 14, 2008&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 36pt; text-indent: -27pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a80f48599-6f34-4c84-9bac-32250859e23a" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Deemed a wholly foreign owned enterprise (&amp;#8220;WFOE&amp;#8221;) under PRC law&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a1f8a1213-49b1-459c-9bd5-42d5b46deeda" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Registered capital of $4,500,000 fully paid&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 9pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;100%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Shouantang Technology&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-left: 0pt; margin-left: 9pt; text-indent: 0pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a27b79f33-193a-4e05-a61e-c309cb2f9ade" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Established in the PRC on July 16, 2010 by Renovation with registered capital of $20 million&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="ae0692953-a046-47eb-b985-c8831a6551b4" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Deemed a WFOE under PRC law&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a97360b22-4b93-4e66-ae5a-3e448a04ea70" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$11 million of registered capital paid,&amp;#160;&amp;#160;with&amp;#160;the balance of $9 million due by July 16, 2012&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="ab1792f92-e2ae-4c2c-bfaa-ac6675814adc" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Invests and finances the working capital of Quannuo Technology&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 9pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;100%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Qianhong Agriculture&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="margin-left: 0pt; text-indent: 9pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="margin-left: 54pt; text-indent: -45pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a99211c7c-e1ac-41d4-b858-fe4eedddd31f" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Established in the PRC on August 10, 2010 by Jiuxin Management&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 36pt; text-indent: -27pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a87fe9e56-22c3-420a-92cc-e333a1db7018" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Registered capital of RMB 10,000,000 fully paid&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a25c7468a-5330-4fe3-a151-f6e2f742c81f" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Carries out cultivation of TCM herbal plants&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 18pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;100%&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;Quannuo Technology&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="margin-left: 0pt; text-indent: 9pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="margin-left: 72pt; text-indent: -63pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="aef9fe524-b6d8-489c-a926-2e8ec89d097c" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Established in the PRC on July 7, 2009&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 54pt; text-indent: -45pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a87bfea78-ed65-40db-a2b6-239c589f824f" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Registered capital of RMB 10,000,000 fully paid&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 36pt; text-indent: -27pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a5374d2b8-21d2-4933-bdf7-4fae83533498" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Acquired by Shouantang Technology in November 2010&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a8be3065d-3583-4280-9ae1-a7cc6d7bef7c" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Operates the Company&amp;#8217;s online pharmacy website and provide software and technical support&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 9pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;100%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Hangzhou Quannuo&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="margin-left: 0pt; text-indent: 9pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="margin-left: 54pt; text-indent: -45pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="abace79a8-52b3-4e39-97b2-62ec0d399882" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Established in the PRC on July 8, 2010 by Quannuo Technology&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 36pt; text-indent: -27pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a4092f984-b46c-45c6-bab5-fd38c0eaa9fe" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Registered capital of RMB 800,000 fully paid&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a6e32b553-e16e-40d9-a219-6f56316aef15" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Operates one &amp;#8220;Quannuo Grand Pharmacy&amp;#8221;&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 9pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;100%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Tonglu Lydia&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="margin-left: 0pt; text-indent: 9pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="margin-left: 54pt; text-indent: -45pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a0fb7f6ec-32fa-4895-9941-6f64998c07fc" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Established in PRC on June 24, 2011 by Shouantang Technology&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 36pt; text-indent: -27pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a5a60c591-50e7-48be-9c42-9246c7c6b3d2" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Registered capital of RMB 5,000,000 fully paid&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a223e27ef-e7b3-4df3-be49-f6baa4a7c0dd" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;To carry out cultivation of TCM herbal plants&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 9pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;100%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Jiuzhou&amp;#160;Pharmacy (1)&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="margin-left: 0pt; text-indent: 9pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="margin-left: 54pt; text-indent: -45pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a8f1475e3-ab4c-491a-b87b-c991d3a879d6" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Established in the PRC on September 9, 2003&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 36pt; text-indent: -27pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a066c3e12-b384-47f6-924c-81f5c03afa9f" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Registered capital of RMB 5 million fully paid&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a7be7e974-3964-4e03-8cb1-326705ac4126" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Operates the &amp;#8220;Hangzhou Jiuzhou Grand Pharmacy&amp;#8221; stores in and around Hangzhou and Jiangshan&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 9pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;VIE&amp;#160;by&amp;#160;contractual&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;arrangements (2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Jiuzhou&amp;#160;Clinic (1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="margin-left: 0pt; text-indent: 9pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="margin-left: 36pt; text-indent: -27pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a386a5b5c-fa80-4d2b-9d9a-426903161d6c" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Established in the PRC as a general partnership on October 10, 2003&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a83fb0896-8b2d-4c31-9778-76b3e5773a38" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Operates a medical clinic adjacent to one of Jiuzhou Pharmacy&amp;#8217;s stores&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 9pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;VIE&amp;#160;by&amp;#160;contractual arrangements (2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Jiuzhou&amp;#160;Service (1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="margin-left: 0pt; text-indent: 9pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="margin-left: 54pt; text-indent: -45pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="ab84ba973-4206-4af6-a1d5-c5876182f5e7" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Established in the PRC on November 2, 2005&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 36pt; text-indent: -27pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="a5f5e3983-10f2-42aa-858a-509500b86396" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Registered capital of RMB 500,000 fully paid&lt;/font&gt;&lt;/div&gt;
&lt;div style="margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font id="ac12aaa8d-19ac-44de-855d-85ec5b614918" style="color: black; letter-spacing: 9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Operates a medical clinic adjacent to one of Jiuzhou Pharmacy&amp;#8217;s stores&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 9pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;VIE&amp;#160;by&amp;#160;contractual&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;arrangements (2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div id="a9aea4175-ba25-4463-a0fb-7567173a6309" style="margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;
&lt;div id="ab7a7afa7-ddec-4812-b32f-deebbcc20466"&gt;
&lt;div align="left" id="glftr" style="width: 100%;"&gt;&lt;font style="display: inline; font-size: 8pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div&gt;
&lt;div&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Shanghai Lydia&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="text-indent: 9pt;" valign="top" width="39%"&gt;
&lt;div align="left" style="display: block; margin-left: 54pt; text-indent: -45pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Established in the PRC on January 31, 2011 by Jiuzhou Pharmacy&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 36pt; text-indent: -27pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Registered capital of RMB 1,000,000 fully paid&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Operates the &amp;#8220;Lydia Grand Pharmacy&amp;#8221; store in Shanghai&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 9pt; margin-right: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;VIE by contractual arrangements as a wholly-owned subsidiary&amp;#160;of Jiuzhou Pharmacy (2)&lt;font style="display: inline; font-family: times new roman;"&gt; &amp;#160; &lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Jiuxin Medicine&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="text-indent: 9pt;" valign="top" width="39%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Established in PRC on December 31, 2003&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Acquired by Jiuzhou Pharmacy in August 2011&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Registered capital of RMB 10 million fully paid&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Carries out pharmaceutical distribution services&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;VIE by contractual arrangements as a wholly-owned subsidiary of Jiuzhou Pharmacy (2)&lt;font style="display: inline; font-family: times new roman;"&gt; &amp;#160; &lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Shanghai Zhongxing&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="text-indent: 9pt;" valign="top" width="39%"&gt;
&lt;div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Established in PRC on June 19, 2006&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Registered capital of RMB 1 million fully paid&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;99% acquired by Shanghai Lydia in July 2011&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Operates the &amp;#8220;Zhongxing Grand Pharmacy&amp;#8221; store in Shanghai&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 9pt; margin-right: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;VIE by contractual arrangements as a controlled entity of Jiuzhou Pharmacy through Shanghai Lydia (2)&lt;font style="display: inline; font-family: times new roman;"&gt; &amp;#160; &lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Jiutong Medical&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-left: 0pt; margin-left: 9pt; text-indent: 0pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Established in the PRC on December 20, 2011 by Renovation with registered capital of $5 million&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;$2 million of registered capital paid, with the balance of $3 million due by December 20, 2012&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;100%&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Jiuying Pharmacy&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="4%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-left: 0pt; margin-left: 9pt; text-indent: 0pt; margin-right: 0pt; text-align: left;" valign="top" width="39%"&gt;
&lt;div style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt; text-align: left;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Established in the PRC on February 27, 2012 with registered capital of RMB 5 million fully paid&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 18pt; text-indent: -9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-family: symbol, serif;"&gt;&amp;#183;&lt;/font&gt;&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;Operates four &amp;#8220;Jiuying Grand Pharmacy&amp;#8221; stores in Hangzhou&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="14%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;VIE by contractual arrangements (3)&lt;font style="display: inline; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td valign="top" width="5%"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;(1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="67%"&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service have been under the common control of the Owners since their respective establishment dates, pursuant to agreements amongst the Owners to vote their interests in concert as memorialized in a voting agreement. Based on such voting agreement, the Company has determined that common control exists among these three companies in accordance with generally accepted accounting standards.&amp;#160;&amp;#160;Operationally, the Owners have operated these three companies in conjunction with one another since each company&amp;#8217;s respective establishment date. Shanghai Lydia, Shanghai Zhongxing and Jiuxin Medicine are also deemed under the common control of the Owners as they are each a subsidiary of Jiuzhou Pharmacy.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td valign="top" width="5%"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;(2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="67%"&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;To comply with certain foreign ownership restrictions of pharmacy and medical clinic operators, Jiuxin Management entered into a series of contractual arrangements with Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service on August 1, 2009. These contractual arrangements are comprised of five agreements: consulting services agreement, operating agreement, equity pledge agreement, voting rights agreement and option agreement. As a result of these agreements, which obligate Jiuxin Management to absorb all of the risks of loss from the activities of Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, and enable the Company (through Jiuxin Management) to receive all of their expected residual returns, the Company accounts for all three companies (as well as the two subsidiaries of Jiuzhou Pharmacy) as a variable interest entity (&amp;#8220;VIE&amp;#8221;) under the accounting standards of the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;). Accordingly, the financial statements of Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, as well as the subsidiaries and entity under the control of Jiuzhou Pharmacy (Shanghai Lydia, Jiuxin Medicine and Shanghai Zhongxing), are consolidated into the financial statements of the Company.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" width="5%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" width="67%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td valign="top" width="5%"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;(3)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="67%"&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;To comply with foreign ownership restrictions, the Company holds 49% of the equity interest (39% through Shouantang Technology and 10% through Jiuxin Management).&amp;#160;&amp;#160;The remaining 51% is held by the Owners but controlled by the Company through contractual arrangements between Jiuxin Management and Jiuying Pharmacy entered into on May 15, 2012.&amp;#160;&amp;#160;Such contractual arrangements are identical to those that Jiuxin Management entered into with Jiuzhou Pharmacy,&amp;#160;&amp;#160;&amp;#160;Jiuzhou Clinic and Jiuzhou Service.&amp;#160;&amp;#160;As such, the Company also accounts for Jiuying Pharmacy as a VIE and consolidates its financial statements into those of the Company.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</cjjd:DescriptionOfBusinessAndOrganizationTextBlock>
  <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; font-weight: bold; display: inline;"&gt;Note 2 &amp;#8211; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Basis of presentation and consolidation&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. The consolidated financial statements include the financial statements of the Company, its wholly-owned subsidiaries and VIEs. All significant inter-company transactions and balances between the Company, its subsidiaries and VIEs are eliminated upon consolidation.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Consolidation of variable interest entities&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;In accordance with accounting standards regarding consolidation of variable interest entities, VIEs are generally entities that lack sufficient equity to finance their activities without additional financial support from other parties or whose equity holders lack adequate decision making ability. All VIEs with which the Company is involved must be evaluated to determine the primary beneficiary of the risks and rewards of the VIE. The primary beneficiary is required to consolidate the VIE for financial reporting purposes.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company has concluded, based on the contractual arrangements, that Jiuzhou Pharmacy (including its subsidiaries and controlled entities), Jiuzhou Clinic and Jiuzhou Service are each a VIE and that the Company&amp;#8217;s wholly-owned subsidiary, Jiuxin Management, absorbs a majority of the risk of loss from the activities of these companies, thereby enabling the Company, through Jiuxin Management, to receive a majority of their respective expected residual returns.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Additionally, as Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service are under common control, the consolidated financial statements have been prepared as if the transactions had occurred retroactively as to the beginning of the reporting period of these consolidated financial statements.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Control and common control is defined under the accounting standards as &amp;#8220;an individual, enterprise, or immediate family members who hold more than 50 percent of the voting ownership interest of each entity.&amp;#8221; Because the Owners collectively own 100% of Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, and have agreed to vote their interests in concert since the establishment of each of these three companies as memorialized the Voting Rights Proxy Agreement, the Company believes that the Owners collectively have control and common control of the three companies. Accordingly, the Company believes that Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service were constructively held under common control by Jiuxin Management as of the time the Contractual Agreements were entered into, establishing Jiuxin Management as their primary beneficiary. Jiuxin Management, in turn, is owned by Renovation, which is owned by the Company.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div id="pgbrk" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt;"&gt;
&lt;div id="ftr"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Although the Company has determined that the accounting standards regarding consolidation of VIEs do not provide for retroactive accounting treatment, Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service in substance were controlled by the Owners on September 9, 2003, October 10, 2003, and November 2, 2005, the establishment dates of Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, respectively. Such common control conditions resulted in the share exchange transaction to be a capital transaction in substance, reflected as a recapitalization, and the Company has accordingly recorded the consolidation of Renovation at its historical cost.&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Risks and Uncertainties&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The operations of the Company are located in the PRC. Accordingly, the Company&amp;#8217;s business, financial condition, and results of operations may be influenced by the political, economic, and legal environments in the PRC, as well as by the general state of the PRC economy. The Company&amp;#8217;s operations in the PRC are subject to special considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environment and foreign currency exchange. The Company&amp;#8217;s results may be adversely affected by changes in the political, regulatory and social conditions in the PRC, and by changes in governmental policies or interpretations with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation, among other things. Although the Company has not experienced losses from these situations and believes that it is in compliance with existing laws and regulations including its organization and structure disclosed in Note 1, this may not be indicative of future results.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company has significant cash deposits with suppliers in order to obtain and maintain inventory. The Company&amp;#8217;s ability to obtain products and maintain inventory at existing and new locations is dependent upon its ability to post and maintain significant cash deposits with its suppliers. In the PRC, many vendors are unwilling to extend credit terms for product sales that require cash deposits to be made. The Company does not generally receive interest on any of its supplier deposits, and such deposits are subject to loss as a result of the creditworthiness or bankruptcy of the party who holds such funds, as well as the risk from illegal acts such as conversion, fraud, theft or dishonesty associated with the third party. If these circumstances were to arise, the Company would find it difficult or impossible, due to the unpredictability of legal proceedings in China, to recover all or a portion of the amount on deposit with its vendors or landlords.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Members of the current management team own controlling interests in the Company and are also the Owners of the VIEs in the PRC. The Company only controls the VIEs through contractual arrangements which obligate it to absorb the risk of loss and to receive the residual expected returns. As such, the controlling shareholders of the Company and the VIEs could cancel these agreements or permit them to expire at the end of the agreement terms, as a result of which the Company would not retain control of the VIEs.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Use of estimates&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The significant estimates made in the preparation of the accompanying consolidated financial statements relate to the assessment of the carrying values of accounts receivable and related allowance for doubtful accounts, useful lives of property and equipment, and fair value of purchase option derivative liability. Because of the use of estimates inherent in the financial reporting process, actual results could materially differ from those estimates.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Fair values of financial instruments&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The accounting standards regarding fair value of financial instruments and related fair value measurements define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The carrying amounts reported in the accompanying consolidated balance sheets for receivables, payables, notes payable and short-term loans qualify as financial instruments and are reasonable estimates of fair values because of the short period of time between the origination of such instruments and their expected realization, and because of their current market rate of interest. The three levels of valuation hierarchy are defined as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td valign="top" width="5%"&gt;
&lt;div align="center" style="text-indent: -18pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: symbol, serif; font-size: 10pt; display: inline;"&gt;&amp;#183;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="67%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td valign="top" width="5%"&gt;
&lt;div align="center" style="text-indent: -18pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: symbol, serif; font-size: 10pt; display: inline;"&gt;&amp;#183;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="67%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td valign="top" width="5%"&gt;
&lt;div align="center" style="text-indent: -18pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: symbol, serif; font-size: 10pt; display: inline;"&gt;&amp;#183;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="67%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Goodwill and other intangible assets&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The excess of the cost of an acquired entity over the net of the amounts assigned to assets acquired and liabilities assumed is recognized as goodwill. Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis in the fourth quarter or more frequently if there are indications of impairment. The Company has elected to early adopt the provisions of Accounting Standards Update ("ASU") 2011-08. Testing Goodwill for Impairment. Under this ASU, The Company may first assess qualitative factors to determine whether it is necessary to perform the two-step goodwill test. Calculating the fair value of the reporting units requires significant estimates and assumption by management. To the extent the carrying amount of a reporting unit exceeds the fair value of the reporting unit, there is an indication that the reporting unit goodwill may be impaired and a second step of the impairment test is performed to determine the amount of the impairment to be recognized, if any. After evaluating all qualitative factors, the Company has determined that it is not more likely than not that the fair value of the indefinitive lived intangible assets, including goodwill, is less than its carrying amount, and therefore no impairment was recorded.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Intangibles other than goodwill&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Intangible assets that are acquired individually or as part of a group of assets, are initially recorded at their fair value. The cost of a group of assets acquired in a transaction is allocated to the individual assets based on their relative fair values.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The estimated useful lives of the Company&amp;#8217;s intangible assets are as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom" width="56%" colspan="2"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center;" valign="top" width="16%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Estimated Useful Life&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="56%" colspan="2"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="16%"&gt;
&lt;div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Indefinite&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="56%" colspan="2"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Licenses and permits&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="16%"&gt;
&lt;div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Indefinite&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="56%" colspan="2"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Software&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="16%"&gt;
&lt;div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;3 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company evaluates intangible assets for impairment whenever events or changes in circumstances indicate that the assets might be impaired. &lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;There was no indication of goodwill or other intangible impairment during the year ended March 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Revenue recognition&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Revenue from sales of prescription medicine at the drugstores is recognized when the prescription is filled and the customer picks up and pays for the prescription.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div id="a54a6caed-6128-4c50-9147-5062a49037f8" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt;"&gt;
&lt;div id="ad02011c8-3ed7-469d-ba8c-de6b8dc5933a"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Revenue from sales of other merchandise at the drugstores is recognized at the point of sale, which is when the customer pays for and receives the merchandise.&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Revenue from medical services is recognized after the service has been rendered to the customer.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Revenue from sales of merchandise to non-retail customers is recognized when the following conditions are met: (1) persuasive evidence of an arrangement exists (sales agreements and customer purchase orders are used to determine the existence of an arrangement); (2) delivery of goods has occurred and risks and benefits of ownership have been transferred, which is when the goods are received by the customer at its designated location in accordance with the sales terms; (3) the sales price is fixed or determinable; and (4) collectability is probable. Historically, sales returns have been de minimis.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company&amp;#8217;s revenue is net of value added tax (&amp;#8220;VAT&amp;#8221;) collected on behalf of PRC tax authorities in respect to the sales of merchandise. VAT collected from customers, net of VAT paid for purchases, is recorded as a liability in the accompanying consolidated balance sheets until it is paid to the relevant PRC tax authorities.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Cash and cash equivalents include cash on hand, cash on deposit with banks and credit and debit card sales transactions which settle within seven days of the fiscal year-end. The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Restricted cash&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company&amp;#8217;s restricted cash consists of cash in a bank as security for its notes payable. The Company has notes payable outstanding with the bank and is required to keep certain amounts on deposit that are subject to withdrawal restrictions. The notes payable are generally short term in nature due to their short maturity period of six to nine months; thus, restricted cash is classified as a current asset.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Accounts receivable&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Accounts receivable represent amounts due from banks relating to retail sales that are paid or settled by the customers&amp;#8217; debit or credit cards, amounts due from government social security bureaus relating to retail sales of drugs, prescription medicine, and medical services that are paid or settled by the customers&amp;#8217; medical insurance cards, and amounts due from non-retail customers for sales of merchandise.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Accounts receivable are recorded at net realizable value consisting of the carrying amount less an allowance for uncollectible accounts, as needed. The Company uses the aging method to estimate the allowance for anticipated uncollectible receivable balances. Under the aging method, bad debt percentages determined by management, based on historical experience and current economic climate, are applied to customers&amp;#8217; balances categorized by the number of months the underlying invoices have remained outstanding. At each reporting period, the allowance balance is adjusted to reflect the amount computed as a result of the aging method. When facts subsequently become available to indicate that the allowance provided requires an adjustment, a corresponding adjustment is made to the allowance account as a change in estimate. The ultimate collection of the Company&amp;#8217;s accounts receivable may take one year. As an additional procedure, delinquent account balances are reserved after management determines that the likelihood of collection is not probable, and known bad debts are written-off against allowance for doubtful accounts when identified. For the years ended March 31, 2012 and 2011, $471,334 and $393,987 in accounts receivable were written off directly while $297,321 and $0 were reserved in allowance for doubtful accounts, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Inventories&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Inventories are stated at the lower of cost or market. Cost is determined using the first in first out (FIFO) method. Market is the lower of replacement cost or net realizable value. The Company carries out physical inventory counts on a monthly basis at each store and warehouse location. Self-cultivated herbs are recorded at its purchase price, which includes direct cost such as seed selection, fertilizer, labor costs and contract fee that are spent in growing herbs on the leased farmland, and indirect cost which includes amortization of farmland development cost. All the costs are accumulated until the time of harvest and then allocated to harvested herbs upon sales. The Company periodically reviews its inventory and records write-downs to inventories for shrinkage losses and damaged merchandise that are identified. Historically, these amounts have not been material to the consolidated financial statements.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; font-weight: bold; display: inline;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div id="aad0cb73e-5624-4aff-9ea1-cd63a9a95538" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt;"&gt;
&lt;div id="hdr"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Property and equipment&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Property and equipment are stated at cost, net of accumulated depreciation or amortization. Depreciation is calculated on the straight-line method over the estimated useful lives of the assets, taking into consideration the assets&amp;#8217; estimated residual value. Leasehold improvements are amortized over the shorter of lease term or remaining lease period of the underlying assets. Following are the estimated useful lives of the Company&amp;#8217;s property and equipment:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="top" width="54%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="18%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 4.5pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Estimated Useful Life&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="54%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Leasehold improvements&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="18%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 4.5pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;3-10 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="top" width="54%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Motor vehicles&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="18%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 4.5pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;5 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="54%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Office equipment &amp;amp; furniture&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="18%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 4.5pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;3-5 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="top" width="54%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Buildings&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="18%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 4.5pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;35 years&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Maintenance, repairs and minor renewals are charged to expense as incurred. Major additions and betterment to property and equipment are capitalized.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Impairment of long lived assets&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company evaluates long lived tangible and intangible assets for impairment, whenever events or changes in circumstances indicate that the carrying value may not be recoverable from its estimated future cash flows. Recoverability is measured by comparing the assets&amp;#8217; net book value to the related projected undiscounted cash flows from these assets, considering a number of factors including past operating results, budgets, economic projections, market trends and product development cycles. If the net book value of the asset exceeds the related undiscounted cash flows, the asset is considered impaired, and a second test is performed to measure the amount of impairment loss. There were no impairments of these assets as of March 31, 2012 and 2011.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Notes payable&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;During the normal course of business, the Company regularly issues bank acceptance bills as a payment method to settle outstanding accounts payables with various material suppliers. The Company records such bank acceptance bills as notes payables. Such notes payable are generally short term in nature due to their short maturity period of six to nine months.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 20pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Income taxes&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company records income taxes pursuant to the accounting standards for income taxes. These standards require the recognition of deferred income tax liabilities and assets for the expected future tax consequences of temporary differences between income tax basis and financial reporting basis of assets and liabilities. Provision for income taxes consists of taxes currently due and the net change in deferred taxes. A valuation allowance is recognized if it is more likely than not that some portion, or all of, a deferred tax asset will not be realized. As of March 31, 2012 and 2011, the Company&amp;#8217;s deferred tax asset amounted to $290,766 and $0, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The FASB&amp;#8217;s accounting standards clarify the accounting and disclosure for uncertain tax positions and prescribe a recognition threshold and measurement attribute for recognition and measurement of a tax position taken or expected to be taken in a tax return. The accounting standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition. No significant penalties, uncertain tax provisions or interest relating to income taxes have been incurred during the years ended March 31, 2012 and 2011.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br  /&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;All of the tax returns of the Company, since inception, are subject to examination by the tax authorities.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Value added tax&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Sales revenue represents the invoiced value of goods, net of value added tax (&amp;#8220;VAT&amp;#8221;). All of the Company&amp;#8217;s products are sold in the PRC and are subject to a VAT on the gross sales price. The VAT rates range up to 17%, depending on the type of products sold. The VAT may be offset by VAT paid by the Company on raw materials and other materials included in the cost of producing or acquiring its finished products. The Company recorded a VAT payable and VAT receivable net of payments in the accompanying financial statements.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Stock based compensation&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees in accordance with the FASB&amp;#8217;s accounting standards regarding accounting for stock-based compensation and accounting for equity instruments that are issued to other than employees for acquiring or in conjunction with selling goods or services. Costs are measured at the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably determinable. The value of equity instruments issued for consideration other than employee services is determined on the earlier of a performance commitment or completion of performance by the provider of goods or services as defined by these accounting standards. In the case of equity instruments issued to consultants, the fair value of the equity instrument is recognized over the term of the consulting agreement.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Advertising and promotion costs&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Advertising and promotion costs are expensed as incurred. Advertising and promotion costs amounted to $929,838 and $458,979 for years ended March 31, 2012 and 2011, respectively. Advertising and promotion costs consist primarily of print and television advertisements.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Pre-opening costs&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Expenditures related to the opening of new drugstores, other than expenditures for property and equipment, are expensed as incurred. &lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Vendor allowances&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company accounts for vendor allowances by reducing the carrying value of inventories that are subsequently transferred to cost of goods sold when the inventories are sold, unless those allowances are specifically identified as reimbursements for advertising, promotion and other services, in which case they are recognized as a reduction of the related advertising and promotion or other service costs.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company recognized vendor allowances of $704,125 and $414,365 in cost of goods sold for the years ended March 31, 2012 and 2011, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Distribution costs&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Distribution costs represent the costs of transporting merchandise from warehouse to stores. These costs are expensed as incurred and are included in sales and marketing costs.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div id="a875ae1f6-6f7d-45b5-9f4d-094df0c2a26b" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt;"&gt;
&lt;div id="a681ec35c-ce90-4930-89c6-d0030be1d521"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Operating leases&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company leases premises for retail drugstores and offices under non-cancelable operating leases. Operating lease payments are expensed over the term of lease. A majority of the Company&amp;#8217;s retail drugstore leases have a 3 to 10-year term with a renewal option upon the expiration of the lease. The Company has historically been able to renew a majority of its drugstores leases. Under the terms of the lease agreements, the Company has no legal or contractual asset retirement obligations at the end of the lease. Land leased from the government is amortized on a straight-line basis over a 30-year term.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Foreign currency translation&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company uses the United States dollar (&amp;#8220;U.S. dollars&amp;#8221; or &amp;#8220;USD&amp;#8221;) for financial reporting purposes. The Company&amp;#8217;s subsidiaries and VIEs maintain their books and records in their functional currency the Renminbi (&amp;#8220;RMB&amp;#8221;), the currency of the PRC.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;In general, for consolidation purposes, the Company translates the assets and liabilities of its subsidiaries and VIEs into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statements of income and cash flows are translated at average exchange rates during the reporting period. As a result, amounts related to assets and liabilities reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheet. Equity accounts are translated at historical rates. Adjustments resulting from the translation of the financial statements of the subsidiaries and VIEs are recorded as accumulated other comprehensive income.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The balance sheet amounts, with the exception of equity, at March 31, 2012 and 2011 were translated at 1 RMB to $0.1581 USD and at 1 RMB to $0.1527 USD, respectively. The average translation rates applied to income and cash flow statement amounts for the years ended March 31, 2012 and 2011 were at 1 RMB to $0.1561 USD and at 1 RMB to $0.14909 USD, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Concentrations and credit risk&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Certain financial instruments, which subject the Company to concentration of credit risk, consist of cash and restricted cash. The Company has cash balances at financial institutions located in Hong Kong and PRC. Balances at financial institutions in Hong Kong may, from time to time, exceed Hong Kong Deposit Protection Board&amp;#8217;s insured limits. Balances at financial institutions and state-owned banks within the PRC are not covered by insurance. As of March 31, 2012 and 2011, the Company had deposits &lt;font style="font-family: times new roman; font-size: 10pt;"&gt;totaling&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;$&lt;/font&gt;6,268,508 and $7,068,093 that were not covered by insurance, respectively. To date, the Company has not experienced any losses in such accounts.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;For the fiscal year ended March 31, 2012, two vendors collectively accounted for 26% of the Company&amp;#8217;s total purchases and 20% of total advances to suppliers. For the fiscal year ended March 31, 2011, two vendors collectively accounted for 27% of the Company&amp;#8217;s total purchases and 11% of advances to suppliers.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;For the fiscal year ended March 31, 2012, no customer accounted for more than 10% of the Company&amp;#8217;s total sales while two customers collectively accounted for 35% of total accounts receivable. For the fiscal year ended March 31, 2011, no customer accounted for more than 10% of the Company&amp;#8217;s total sales or accounts receivable.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Noncontrolling interest&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;As of March 31, 2012, 1% of the equity interests of Shanghai Zhongxing was owned by Shanghai Bieyanghong Grand Pharmacy Co., Ltd. and not under the Company's control.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br  /&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Business combinations&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company accounts for business combinations using the acquisition method of accounting. The acquisition method requires an acquirer to recognize the assets acquired, the liabilities assumed, and any noncontrolling interest in the acquiree at the acquisition date, measured at their fair values as of that date.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Reclassification&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications had no effect on net income or cash flows as previously reported.&lt;/font&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
  <cjjd:OtherCurrentAssetsDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note 3 &amp;#8211; OTHER CURRENT ASSETS&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Other current assets as of March 31, 2012 and 2011 consisted of the following:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Prepaid rental expenses&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;1,994,280&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;1,316,626&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Lease rights transfer fees (1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;402,735&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;380,981&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Security deposit with vendor&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right"
 valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;4,581,132&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Prepaids and other current assets&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;456,286&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;166,148&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Advance to contractor&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;1,919,380&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2,853,301&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;8,364,267&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="top" width="4%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="middle" width="68%"&gt;
&lt;div
 align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Lease rights transfer fees are paid by the Company to secure store rentals in coveted areas. These additional costs of acquiring the right to lease new store locations are capitalized and amortized over the period of the initial lease term.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</cjjd:OtherCurrentAssetsDisclosureTextBlock>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note 4 &amp;#8211; PROPERTY AND EQUIPMENT&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Property and equipment as of March 31, 2012 and 2011 consisted of the following:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Building&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;1,109,926&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Leasehold improvements&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;11,423,330&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;3,481,773&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Office equipment and furniture&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;4,808,721&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display:
 inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;867,304&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Motor vehicles&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;420,985&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;269,275&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;17,762,962&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;4,618,352&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Less: Accumulated depreciation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(4,814,490)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(2,661,615)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Construction-in-progress&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2,698,648&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times
 new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;3,514,695&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Property and equipment, net&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;15,647,120&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;5,471,432&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Construction-in-progress, as of March 31, 2012, includes leasehold improvements in progress at the newly leased store locations. The construction works are expected to be finished within one year. &amp;#160;These stores are currently under remodeling and are not in operation.&amp;#160;&amp;#160;No depreciation is provided for construction-in-progress until such time as the assets are completed and placed into service.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Total depreciation expense for property and equipment was $2,032,786 and $622,001 for the years ended March 31, 2012 and 2011, respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <cjjd:AdvancesToSuppliersTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note 5 &amp;#8211; ADVANCES TO SUPPLIERS&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Advances to suppliers consist of deposits with or advances to outside vendors for future inventory purchases. Most of the Company&amp;#8217;s vendors require a certain amount of money to be deposited with them as a guarantee that the Company will receive its purchase on a timely basis. This amount is refundable and bears no interest.&amp;#160;&amp;#160;As of March 31, 2012 and 2011, advances to suppliers amounted to $14,347,557 and $16,528,772, respectively.&amp;#160;&amp;#160;For the years ended March 31, 2012 and 2011, $1,029,413 and $0 of advances to suppliers were reserved in allowance for doubtful accounts, respectively.&lt;/font&gt;&lt;/div&gt;</cjjd:AdvancesToSuppliersTextBlock>
  <cjjd:LongTermDepositsLandlordsTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note 6 &amp;#8211; LONG TERM DEPOSITS, LANDLORDS&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Long term deposits are money deposited with or advanced to landlords for securing retail store leases for which the Company does not anticipate applying or being returned within the next twelve months. Most of the Company&amp;#8217;s landlords require a minimum of nine months&amp;#8217; rent being paid upfront plus additional deposits.&lt;/font&gt;&lt;/div&gt;</cjjd:LongTermDepositsLandlordsTextBlock>
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note 8 &amp;#8211; INTANGIBLE ASSETS&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Net intangible assets as of March 31, 2012 and 2011 consisted of the following at:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31, &lt;br /&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Goodwill on acquisition of Jiuxin Medicine&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;1,401,451&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Goodwill on acquisition of Shanghai Zhongxing&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;69,549&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Licenses and permits&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;1,095,792&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left"
 valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Software&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;461,820&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;446,059&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Total goodwill and other intangible assets&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;3,028,612&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;446,059&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Less: accumulated amortization&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(211,667&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(55,757&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 27pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Intangible assets, net&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new
 roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2,816,945&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;390,302&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Amortization expense of intangibles for the year ended March 31, 2012 and 2011 amounted to $151,993 and $54,439, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Amortization expense for the next five years and thereafter is as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 27pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-left: 0pt; margin-left: 9pt;" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;153,940&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2014&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;96,213&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2015&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 9pt; margin-right: 0pt;"&gt;&lt;font style="display:
 inline; font-family: times new roman; font-size: 10pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Thereafter&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 9pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;250,153&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
  <cjjd:TaxDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note&amp;#160;9 &amp;#8211; TAXES&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&lt;font style="display: inline; text-decoration: underline;"&gt;Income tax&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;The Company is subject to income taxes on an entity basis on income arising in or derived from the tax jurisdiction in which each entity is domiciled.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td style="border-bottom: black 2px solid;" valign="top" width="22%"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Entity&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="2%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="top" width="22%"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Income Tax Jurisdiction&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="22%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Jo-Jo Drugstores&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="2%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" width="22%"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;United States&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="top" width="22%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Renovation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="2%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" width="22%"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Hong Kong&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="top" width="22%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;All other entities&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="2%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="top" width="22%"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;PRC&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Jo-Jo Drugstores is incorporated in the U.S. and has incurred a net operating loss for income tax purposes for 2012 and 2011. As of March 31, 2012, the estimated net operating loss carry forwards for U.S. income tax purposes amounted to approximately $2,000,000 which may be available to reduce future years&amp;#8217; taxable income. These carry forwards will expire, if not utilized by 2031. Management believes that the realization of the benefits arising from this loss appears to be uncertain due to the Company&amp;#8217;s limited operating history and continuing losses for U.S. income tax purposes. Accordingly, the Company has provided a 100% deferred tax asset valuation allowance at March 31, 2012 and no deferred tax asset benefit has been recorded. The valuation allowance at March 31, 2012 was $411,000.&amp;#160; The net change in the valuation allowance was an increase of $134,000. The Company&amp;#8217;s management reviews this valuation allowance periodically and makes adjustments as necessary.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Significant components of the income tax provision were as follows for the year ended March 31, 2012 and 2011:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;For the years ended March 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Current tax provision&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="2"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-left: 0pt; margin-left: 446pt;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Federal&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-left: 0pt; margin-left: 446pt;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;State&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px; padding-left: 0pt; margin-left: 446pt;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2,939,131&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new"&gt;3,523,345&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2,939,131&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;3,523,345&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Deferred tax provision&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-left: 0pt; margin-left: 446pt;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Federal&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-left: 0pt; margin-left: 446pt;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;State&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 2px; padding-left: 0pt; margin-left: 446pt;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(290,766&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(290,766&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Income tax provision&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2,648,365&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;3,523,345&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Income from continuing operations before income taxes were allocated between the United States and foreign components for the year ended March 31, 2012 and 2011 as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="7"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;For the years ended March 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="3"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="3"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;United States&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(490,726&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(718,167&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;)&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Foreign&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;11,279,570&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;12,673,970&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;10,788,844&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;11,955,803&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;div&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;The Company recognizes interest and penalties accrued related to unrecognized tax benefits and penalties, if any, as income tax expense.&amp;#160;&amp;#160;The Company files U.S. federal and state income tax returns.&amp;#160;&amp;#160;With few exceptions, the Company was subject to the U.S. federal and state income tax examinations by tax authorities for years on or after 2007.&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;The Company&amp;#8217;s subsidiaries and VIEs in China file income tax returns with both the state and local tax bureaus in the PRC.&amp;#160;&amp;#160;&amp;#160;Such income tax returns are subject to examinations by these foreign tax authorities and have passed all examinations since each subsidiary&amp;#8217;s and VIE&amp;#8217;s inception date.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;The following table reconciles the U.S. statutory tax rates&amp;#160;with the Company's effective tax rate for the years ended March 31, 2012 and 2011:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;U.S. Statutory rates&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.35pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;34.0%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;34.0%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Foreign income not recognized in the U.S.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.35pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(34.0)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(34.0)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;China income taxes&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.35pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;25.0&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;25.0&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Other (a)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.35pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(0.5)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;4.4&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Effective tax rate&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 3.35pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;24.5%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;29.4%&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="top" width="3%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(a)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="69%"&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 4.4pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;The (0.5)% for the year ended March 31, 2012 represents the combined effect of expenses incurred by the Company that were not deductible for PRC income tax and PRC income tax exemptions.&amp;#160;&amp;#160;&amp;#160;The 4.4% for the year ended March 31, 2011 represents expenses incurred by the Company that were not deductible for PRC income tax.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;The Company had cumulative undistributed earnings of foreign subsidiaries of approximately $32.6 million&amp;#160;as of March 31, 2012,&amp;#160;which are included in consolidated retained earnings and will continue to be indefinitely reinvested in international operations. &amp;#160;Accordingly, no provision has been made for U.S. deferred taxes related to future repatriation of these earnings.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&lt;font style="display: inline; text-decoration: underline;"&gt;Value added tax&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;VAT on sales and on purchases amounted to $17,778,942 and $14,285,240 for the year ended March 31, 2012, and $11,451,967 and $8,230,455 for the year ended March 31, 2011, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Sales and purchases are recorded net of VAT collected and paid as the Company acts as an agent for the government. VAT taxes are not impacted by the income tax holiday.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Taxes payable at March 31, 2012 and 2011 consisted of the following:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;VAT&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;435,390&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;421,562&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Income tax&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;7,240&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;1,146,453&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Others&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;26,976&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;56,543&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Total taxes payable&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;469,606&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;1,624,558&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</cjjd:TaxDisclosureTextBlock>
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note 10 &amp;#8211; POSTRETIREMENT BENEFITS&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Regulations in the PRC require the Company to contribute to a defined contribution retirement plan for all permanent employees. The contribution for each employee is based on a percentage of the employee&amp;#8217;s current compensation as required by the local government. The Company contributed $540,226 and $255,610 in employment benefits and pension for the years ended March 31, 2012 and 2011, respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note 11 &amp;#8211; RELATED PARTY TRANSACTIONS AND ARRANGEMENTS&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Amounts receivable from and payable to related parties as of March 31, 2012 and 2011 are summarized as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Due to cofounders (1):&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;880,058&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;800,058&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Due to director (2):&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;578,383&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="top" width="1%"&gt;
&lt;div
 align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;1,458,441&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;800,058&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 4.4pt;"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;"  border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr valign="top"&gt;
&lt;td align="right" style="width: 18pt;"&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 4.4pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left"&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 4.4pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;As of March 31, 2012 and 2011, amount due to cofounders represents contributions from the Owners to Jiuxin Management to enable Jiuxin Management to meet its approved PRC registered capital requirements.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;"  border="0" cellspacing="0" cellpadding="0"&gt;
&lt;tr valign="top"&gt;
&lt;td align="right" style="width: 18pt;"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Due to foreign exchange restrictions, Mr. Lei Liu, personally lent U.S. dollars to the Company to facilitate its payments of expenses in the United States.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;As of March 31, 2012 and March 31, 2011, notes payable totaling 4,208,928 and $1,609,336 were secured by the personal properties of certain of the Company&amp;#8217;s shareholders, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;One of the Company&amp;#8217;s retail spaces and its corporate office are&amp;#160;leased from&amp;#160;Mr. Liu under long-term operating lease agreements from&amp;#160;August 2010 to August 2012 and from January 2011 to December 2012, respectively. For the years ended March 31, 2012 and 2011, rents paid to Mr. Liu amounted to $187,320 and $178,912, respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
  <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note 12 &amp;#8211; PURCHASE OPTION DERIVATIVE LIABILITY&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;In connection with the public offering of the Company&amp;#8217;s common stock that closed on April 28, 2010, the Company issued to its underwriters, Madison Williams and Company and Rodman &amp;amp; Renshaw, LLC, an option for $100 to purchase up to a total of 105,000 shares of common stock (3% of the shares sold in the public offering) at $6.25 per share (125% of the price of the shares sold in the public offering). The option is exercisable commencing on October 23, 2010 and expires on April 22, 2015.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;The Company is treating the common shares underlying the option as a derivative liability as the strike price of the option is denominated in U.S. dollars, a currency other than the Company&amp;#8217;s functional currency, the Chinese RMB.&amp;#160;As a result, the option is not considered indexed to the Company&amp;#8217;s own stock, and as such, all future changes in the fair value of the option&amp;#160;are recognized currently in earnings until such time as the option is exercised or expired.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;On April 22, 2010, the issue date of the option, the Company classified the fair value of this option as a liability resulting in a decrease of additional paid-in capital of $402,451 and the establishment of a $402,451 in liability to recognize the option&amp;#8217;s fair value. The Company recognized a gain of $118,807 from the change in fair value of the option liability for the year ended March 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;This option does not trade in an active securities market, and as such, the Company&amp;#160;estimates its fair value using the Black-Scholes Option Pricing Model (the &amp;#8220;Black-Scholes Model&amp;#8221;) on the date that the option was originally issued and as of March 31, 2012 using the following assumptions:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="4"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: -4pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Underwriter Purchase Option&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="4"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="4"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2012 (1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" colspan="4"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Stock price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;1.16&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Exercise price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;6.25&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Annual dividend yield&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;0&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Expected term (years)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;3.05&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;0.51&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Expected volatility&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;96.32&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;%&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="2%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="top" width="66%"&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;As of March 31, 2012, the option to purchase 105,000 shares of common stock had not been exercised.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Expected volatility is based on historical volatility.&amp;#160;Historical volatility&amp;#160;is computed using daily pricing observations for recent periods that correspond to the term of the option. The Company believes this method produces an estimate that is representative of future volatility over the expected term of this option. The expected life is based on the remaining term of the option. The risk-free interest rate is based on U.S. Treasury securities according to the remaining term of the option.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Depending on the product and the terms of the transaction, the fair values of option liability are modeled using a series of techniques, including closed-form analytic formula such as the Black-Scholes Model, which does not entail material subjectivity because the methodology employed does not necessitate significant judgment, and the pricing inputs are observed from actively quoted markets.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;The fair value of the 105,000 shares underlying the option outstanding as of March 31, 2012 was determined using the Black-Scholes Model, with certain inputs significant to the valuation methodology as level 2 inputs, and the Company recorded the change in fair value in earnings. As a result, the option liability is carried on the consolidated balance sheets at fair value.&lt;/font&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note 13 &amp;#8211; STOCKHOLDER&amp;#8217;S EQUITY&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&lt;font style="display: inline; text-decoration: underline;"&gt;Common stock&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;On April 9, 2010, the Company affected a 1-for-2 reverse split of its issued and outstanding shares of common stock and a proportional reduction of its authorized shares of common stock. All share and per share amounts used in the Company&amp;#8217;s consolidated financial statements and accompanying notes have been retroactively restated to reflect the 1-for-2 reverse stock split.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;On April 28, 2010, the Company closed a public offering of 3.5 million shares of common stock at $5.00 per share with gross proceeds of approximately $17.5 million.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&lt;font style="display: inline; text-decoration: underline;"&gt;Stock-based compensation&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;On March 15, 2011, the Company agreed to issue 11,268 shares of restricted common stock to Mr. Marc Serrio, a non-executive director, for his annual service. The terms of the service agreement was continued on March 15, 2012, and 33,058 shares of restricted common stock are to be issued accordingly. The trading value of the Company&amp;#8217;s common stock on March 15, 2012 and 2011 was $1.21 and $3.55, respectively. &amp;#160;Accordingly, $40,000 and $40,000 were charged to general and administrative expense year ended March 31, 2012 and 2011, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;On May 1, 2010, the Company agreed to issue 6,000 shares of common stock to Mr. Ming Zhao as partial payment for compensation. 500 shares were vested as for the year ended March 31, 2012. On August 1, 2011, the Company appointed Mr. Ming Zhao as its chief financial officer, and in connection therewith, entered into an agreement pursuant to which the Company agreed to issue to Mr. Zhao 40,000 shares of restricted common stock under the Plan, to be vested in eight equal quarterly installments over two years. The trading values of the Company&amp;#8217;s common stock on May 1, 2010 and August 1, 2011 were $4.80 and $1.70, respectively.&amp;#160; Accordingly, $25,036 was charged to general and administrative expense for the year ended March 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;On May 14, 2010, the Company entered into an agreement pursuant to which the Company agreed to issue 14,000 shares of restricted common stock in connection with the services of Mr. Bennet P. Tchaikovsky as chief financial officer through April 27, 2011, upon the adoption of a stock incentive plan (the &amp;#8220;Plan&amp;#8221;). 739 shares were vested as for the year ended March 31, 2012.&amp;#160; On August 1, 2011, the Company entered into an agreement pursuant to which the Company agreed to issue 4,613 shares of restricted common stock under the Plan in connection with Mr. Tchaikovsky&amp;#8217;s services as chief financial officer from April 28, 2011 to August 1, 2011.&amp;#160; On August 1, 2011, the Company appointed Mr. Tchaikovsky to its Board of Directors, and in connection therewith, entered into an agreement pursuant to which the Company agreed to issue to Mr. Tchaikovsky 5,883 shares of its restricted common stock under the Plan, of which 3,917 shares were vested for the year ended March 31, 2012.&amp;#160; The trading values of the Company&amp;#8217;s common stock on May 14, 2010, April 28, 2011, and August 1, 2011 were $4.66, $2.71, and $1.70, respectively. Accordingly, $22,603 was charged to general and administrative expense for the year ended March 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;On November 1, 2010, the Company agreed to issue 2,340 shares of common stock to its legal counsel as partial payment for six months of legal services. On May 1, 2011, the Company agreed to issue an additional 2,340 shares of common stock to its legal counsel as partial payment for another six months of legal services. The terms of the service agreement was continued on November 1, 2011, and 2,340 shares of restricted common stock to be issued accordingly. The trading value of the Company&amp;#8217;s common stock on November 1, 2011, May 1, 2011 and November 1, 2010 were $1.66, $2.71 and $5.00, respectively.&amp;#160; $11,528 was recorded as service compensation expense for the year ended March 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;On January
 16, 2012, the Company granted a total of 297,000 shares of restricted common stock under the Plan to a group of 46 employees. These restricted shares will vest on January 16, 2015, provided that the employees are still employed by the Company on such date. $15,988 and $6,541 were charged to general and administrative expense and selling expense respectively for the year ended March 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&lt;font style="display: inline; text-decoration: underline;"&gt;Statutory reserve&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Statutory reserves represent restricted retained earnings. Based on their legal formation, the Company is required to set aside 10% of its net income as reported in their statutory accounts on an annual basis to the Statutory Surplus Reserve Fund (the &amp;#8220;Reserve Fund&amp;#8221;). Once the total amount set aside in the Reserve Fund reaches 50% of the entity&amp;#8217;s registered capital, further appropriations become discretionary. The Reserve Fund can be used to increase the entity&amp;#8217;s registered capital upon approval by relevant government authorities or eliminate its future losses under PRC GAAP upon a resolution by its board of directors. The Reserve Fund is not distributable to shareholders, as cash dividend or otherwise, except in the event of liquidation.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Appropriations to the Reserve Fund are accounted for as a transfer from unrestricted earnings to statutory reserves. During the years ended March 31, 2012 and 2011, the Company did not make appropriations to the statutory reserves. The other subsidiaries were still in the development stage and had not allocated any contribution to the statutory surplus reserve fund.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;There are no legal requirements in the PRC to fund the Reserve Fund by transfer of cash to any restricted accounts, and the Company does not do so.&lt;/font&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:EarningsPerShareTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; font-weight: bold; display: inline;"&gt;Note 14 &amp;#8211; EARNINGS PER SHARE&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company reports earnings per share in accordance with the provisions of the FASB&amp;#8217;s related accounting standard. This standard requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution, but includes vested restricted stocks and is computed by dividing income available to common stockholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that could occur if securities or other contracts to issue common stock were exercised and converted into common stock.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The following is a reconciliation of the basic and diluted earnings per share computation:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" colspan="7"&gt;
&lt;div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Years Ended&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: center; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="7"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt; &lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;March 31,&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Net income attributable to controlling interest&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;8,141,626&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;8,432,458&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Weighted average shares used in basic computation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;13,568,481&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;13,254,792&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Diluted effect of restricted shares&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;1,514&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Weighted average shares used in diluted computation&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;13,569,995&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;13,254,792&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Earnings per share &amp;#8211; Basic:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-left: 5%;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Net income before noncontrolling interest&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.60&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.64&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-left: 5%;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Add: Net loss attributable to noncontrolling interest&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-left: 5%;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Net income attributable to controlling interest&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.60&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.64&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Earnings per share &amp;#8211; Diluted:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-left: 5%;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Net income before noncontrolling interest&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.60&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.64&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-left: 5%;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Add: Net loss attributable to noncontrolling interest&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.00&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;-&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-left: 5%;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Net income attributable to controlling interest&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.60&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.64&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="font-weight: bold; display: inline;"&gt; &lt;/font&gt;For the year ended March 31, 2012 and 2011, 105,000 shares underlying outstanding purchase options were excluded from the diluted earnings per share calculation as they are anti-dilutive.&lt;font style="font-weight: bold; display: inline;"&gt; &lt;/font&gt;&lt;/font&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"&gt;Note 15 &amp;#8211; SEGMENTS&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;The Company operates within two main reportable segments: retail drugstores and drug wholesale.&amp;#160;&amp;#160;The retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplement, medical devices, and sundry items to retail customers.&amp;#160;&amp;#160;The drug wholesale segment supplies the retail&lt;font style="display: inline; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;drugstores and sells prescription and over-the-counter medicines, TCM, dietary supplement, medical devices, Chinese white liquor and sundry items in batch to other drug vendors and hospitals. The Company&amp;#8217;s herbal plant cultivation is included in the wholesale segment. The Company is also involved in online pharmacy and clinic services that do not meet the quantitative thresholds for reportable segments and are included in the retail segment.&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Both segments' accounting policies are the same as those described in the summary of significant accounting policies. The Company evaluates performance based on profit or loss from operations before interest and income taxes not including nonrecurring gains and losses.&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;The Company's reportable business segments are strategic business units that offer different products and services. Each segment is managed separately because they require different operation and markets to distinct classes of customers.&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;The following table presents summarized information by segment:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Retail Drugstores&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Drug Wholesale&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="64%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Revenue&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;66,074,348&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;28,278,537&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;94, 352,885&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="64%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Cost of goods&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;44,289,323&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;22,500,761&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;66,790,084&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="64%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Gross profit&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;21,785,025&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;5,777,776&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;27,562,801&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="64%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Income from operations&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;7,975,921&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;2,506,251&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$10,482,172&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="64%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Depreciation and amortization&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;2,057,166&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;283,699&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$2,340,865&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="64%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Total capital expenditures&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;4,782,988&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;132,253&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$4,915,241&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="64%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Total assets&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;48,239,376&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;26,721,637&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 4px double; text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$74,961,013&lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 4px; text-align: left;" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;The Company does not have long-lived assets located outside the PRC.&amp;#160;In accordance with the enterprise-wide disclosure requirements of FASB&amp;#8217;s accounting standard, the Company's net revenue from external customers through its retail stores by main products is as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-weight: bold; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Years&amp;#160;Ended&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Prescription Drugs&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;28,424,237&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;27,118,482&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Over-The-Counter (OTC) Drugs&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;19,487,835&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;23,715,596&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Nutritional Supplements&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;7,060,574&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;5,894,410&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Traditional Chinese Medicine (TCM)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;8,738,394&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;7,364,943&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Chinese White Liquor&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;-&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;3,491,743&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Sundry Products&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;1,039,234&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;1,465,722&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Medical Devices&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;1,324,074&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;918,583&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;66,074,348&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;69,969,479&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="display: block; text-indent: 0pt;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;The Company&amp;#8217;s net revenue from external customers through wholesales by main products is as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;div&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="font-size: 10pt; width: 100%; font-family: arial;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="6"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Years&amp;#160;Ended&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;March 31,&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Prescription Drugs&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;14,262,802&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Over-The-Counter (OTC) Drugs&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;5,917,032&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Nutritional Supplements&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;3,074,101&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Traditional Chinese Medicine (TCM)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;4,923,672&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Sundry Products&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;36,510&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Medical Devices&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;64,420&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;28,278,537&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom"&gt;
&lt;div align="left" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom"&gt;
&lt;div align="right" style="display: block; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;-&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom"&gt;&lt;font style="display: inline; font-size: 10pt; font-family: times new roman;"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; font-weight: bold; display: inline;"&gt;Note 16 &amp;#8211; BUSINESS COMBINATIONS&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Quannuo Technology&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;On November 19, 2010, Shouantang entered into Equity Ownership Transfer Agreements with the owners of Quannuo Technology to acquire 100% of equity interests of Quannuo Technology and its subsidiary, Hangzhou Quannuo. Quannuo Technology operates the Company&amp;#8217;s online pharmacy and provides software and technical supports.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Shouantang acquired all assets and assumed all liabilities of Quannuo Technology. The consideration of the transaction included a cash payment of $606,800 (RMB 4,000,000) to pay off outstanding loans with the former owners, with the excess capitalized by the Company as intangible assets of approximately $443,125. Amortization expense of the intangible assets was $151,993 for the year ended March 31, 2012.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&lt;br  /&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Shanghai Zhongxing&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;On July 29, 2011, Shanghai Lydia obtained control of Shanghai Zhongxing pursuant to an agreement entered into on the same date to acquire 99% of the equity interests of Shanghai Zhongxing for a total consideration of $76,874 (RMB 495,000), including $30,284 (RMB 195,000) for Mr. Xiuyan Liu&amp;#8217;s 39%, and $46,590 (RMB 300,000) for Mr. Xudong Fan&amp;#8217;s 60%.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;font style="text-decoration: underline; display: inline;"&gt;Jiuxin Medicine&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;On August 25, 2011, Jiuzhou Pharmacy completed its acquisition of Jiuxin Medicine. Jiuxin Medicine is a wholesale drug distributor and is licensed to distribute prescription and non-prescription pharmaceutical products throughout China. Jiuzhou Pharmacy acquired all assets and assumed all liabilities of Jiuxin Medicine. The consideration of the transaction included a cash payment of $4,665,000 (RMB 30,000,000). The excess purchase price over the fair value of the assets acquired was capitalized by the Company as goodwill and totaled $1,378,404.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The following table summarizes the preliminary fair value of the assets acquired and liabilities assumed at the date of acquisition:&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Total purchase price&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;4,665,000&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Allocation of the purchase price to assets and liabilities at fair value:&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Cash and cash equivalents&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;910,857&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Notes receivable&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;16,350&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Accounts receivable&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;3,582,440&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Inventories&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;4,069,960&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Advances on inventory purchases&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;1,920,413&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Other assets, current&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;220,390&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Current assets&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;10,720,410&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Property, plant and equipment&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;181,626&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Licenses and permits&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;1,077,771&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Other noncurrent assets&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;262,539&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Total assets&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;12,242,346&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Accounts payable&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;4,220,762&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Tax receivable&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;(43,506&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Accrued liabilities and other liabilities, current&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;4,778,494&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Total liabilities&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;8,955,750&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="88%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Net assets acquired at fair value&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;3,286,596&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="88%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td style="padding-bottom: 4px;" valign="bottom" width="88%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;1,378,404&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The following unaudited pro forma condensed income statement for the years ended March 31, 2012 and 2011 was prepared under generally accepted accounting principles, as if the acquisition of Jiuxin Medicine had occurred the first day of the respective periods. The pro forma information may not be indicative of the results that actually would have occurred if the acquisition had been in effect from and on the date indicated.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Pro Forma&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="6"&gt;
&lt;div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Year Ended March 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td valign="bottom" width="76%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Sales&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;102,992,105&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;73,139,805&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Cost of Goods Sold&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;75,301,760&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;51,791,827&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 2px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Gross Profit&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;27,690,346&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;21,347,978&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Net Income&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;7,982,637&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;8,334,073&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Net income per share - basic&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.59&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.63&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Net income per share - diluted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.59&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;0.63&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Weighted average shares outstanding - basic&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;13,568,481&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;13,254,792&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Weighted average shares outstanding - diluted&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;13,569,995&lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; padding-bottom: 4px;" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: left; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="text-align: right; border-bottom-color: black; border-bottom-width: 4px; border-bottom-style: double;" valign="bottom" width="9%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;13,254,792&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; font-weight: bold; display: inline;"&gt;Note 17 &amp;#8211; COMMITMENTS AND CONTINGENCIES&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;&lt;font style="text-decoration: underline; display: inline;"&gt;Operating lease commitments&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company recognizes lease expense on a straight line basis over the term of its leases in accordance with the relevant accounting standards. The Company has entered into various tenancy agreements for its store premises and for the land leased from a local government for the cultivation of Chinese medicinal herbs.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;The Company&amp;#8217;s commitments for minimum rental payments under its leases for the next five years and thereafter are as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Years ending March 31,&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom-color: black; border-bottom-width: 2px; border-bottom-style: solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Amount&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="top"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;2013&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;4,253,130&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;2014&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;3,732,591&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;2015&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;3,275,615&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;2016&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;1,913,631&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;2017&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;1,003,128&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" valign="bottom" width="88%"&gt;
&lt;div align="left" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Thereafter&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="top" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;3,538,034&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="top" width="1%"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;Total rent expense amounted to $4,315,671 and $2,807,170 for the years ended March 31, 2012 and 2011, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;As of March 31, 2012 and 2011, prepayment on retail and office leases amounted to $1,994,280 and $1,316,626, respectively.&lt;/font&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; font-weight: bold; display: inline;"&gt;Note 18 &amp;#8211; SUBSEQUENT EVENTS&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; margin-right: 0pt; margin-left: 0pt; display: block;"&gt;&lt;font style="font-family: times new roman; font-size: 10pt; display: inline;"&gt;On May 15, 2012, Jiuxin Management entered into a series of contractual arrangements with Jiuying Pharmacy. The contractual arrangements are identical to those that Jiuxin Management entered into with Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service (see Note 1 &amp;#8211; Description of Business and Organization).&lt;/font&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <dei:EntityPublicFloat decimals="0" contextRef="Context_As_Of_22-Jun-2012" unitRef="USD">7944871</dei:EntityPublicFloat>
  <dei:EntityWellKnownSeasonedIssuer contextRef="Context_FYE_31-Mar-2012">No</dei:EntityWellKnownSeasonedIssuer>
  <us-gaap:OtherAssetsMiscellaneousNoncurrent decimals="0" contextRef="Context_As_Of_31-Mar-2011" unitRef="USD">6075478</us-gaap:OtherAssetsMiscellaneousNoncurrent>
  <us-gaap:OtherAssetsMiscellaneousNoncurrent decimals="0" contextRef="Context_As_Of_31-Mar-2012" unitRef="USD">5776667</us-gaap:OtherAssetsMiscellaneousNoncurrent>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">-332971</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
  <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">350885</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
  <cjjd:PaymentsOnLeaseholdImprovementsAndConstructionInProgress decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">4200180</cjjd:PaymentsOnLeaseholdImprovementsAndConstructionInProgress>
  <cjjd:PaymentsOnLeaseholdImprovementsAndConstructionInProgress decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">6639268</cjjd:PaymentsOnLeaseholdImprovementsAndConstructionInProgress>
  <cjjd:ProceedsFromPaymentForOtherPayablesRelatedParties decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">-54942</cjjd:ProceedsFromPaymentForOtherPayablesRelatedParties>
  <cjjd:ProceedsFromPaymentForOtherPayablesRelatedParties decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">577183</cjjd:ProceedsFromPaymentForOtherPayablesRelatedParties>
  <us-gaap:ProceedsFromContributedCapital decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">406546</us-gaap:ProceedsFromContributedCapital>
  <cjjd:TransferFromConstructionInProgressToPropertyAndEquipment decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">2890399</cjjd:TransferFromConstructionInProgressToPropertyAndEquipment>
  <cjjd:OtherNoncurrentsAssetsTextBlock contextRef="Context_FYE_31-Mar-2012">&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt; font-weight: bold;"&gt;Note 7 &amp;#8211; OTHER NONCURRENT ASSETS&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Other noncurrent assets as of March 31, 2012 and 2011 consisted of the following:&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;div align="left"&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2012&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td style="border-bottom: black 2px solid;" valign="bottom" colspan="2"&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;March 31,&lt;/font&gt;&lt;/div&gt;
&lt;div align="center" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;2011&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Prepayment for lease of land use right &amp;#8211; noncurrent (1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;5,533,500&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" valign="bottom" width="1%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;5,497,358&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="white"&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Lease rights transfer fees-noncurrent (2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.1pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;243,167&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 2px solid;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 2px solid;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 1.1pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;578,120&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 2px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr bgcolor="#cceeff"&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="76%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 18pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="left" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left:
 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;5,776,667&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="1%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="right" style="border-bottom: black 4px double;" valign="bottom" width="9%"&gt;
&lt;div align="right" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;6,075,478&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" style="padding-bottom: 4px;" valign="bottom" width="1%"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;
&lt;table style="width: 100%; font-family: arial; font-size: 10pt;" cellspacing="0" cellpadding="0"&gt;
&lt;tr&gt;
&lt;td align="left" valign="top" width="3%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td align="left" valign="middle" width="69%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;This is a payment made to a local government in connection with entering into a 30-year operating land lease agreement. Amortization of land use right amounted to $156,100 and $155,500 for the year ended March 31, 2012 and 2011, respectively.&lt;/font&gt;&lt;/div&gt;
&lt;div style="text-indent: 0pt; display: block;"&gt;&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td align="left" valign="top" width="3%"&gt;
&lt;div align="left" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;(2)&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td valign="middle" width="69%"&gt;
&lt;div align="justify" style="text-indent: 0pt; display: block; margin-left: 0pt; margin-right: 0pt;"&gt;&lt;font style="display: inline; font-family: times new roman; font-size: 10pt;"&gt;Lease rights transfer fees are paid by the Company to secure store rentals in coveted areas. These additional costs of acquiring the right to lease new store locations are capitalized and amortized over the period of the initial lease term.&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;</cjjd:OtherNoncurrentsAssetsTextBlock>
  <cjjd:AdjustmentsToAdditionalPaidinCapitalReclassificationOfPurchaseOptionToDerivativeLiabilities decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">-402451</cjjd:AdjustmentsToAdditionalPaidinCapitalReclassificationOfPurchaseOptionToDerivativeLiabilities>
  <cjjd:AdjustmentsToAdditionalPaidinCapitalReclassificationOfPurchaseOptionToDerivativeLiabilities decimals="0" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">-402451</cjjd:AdjustmentsToAdditionalPaidinCapitalReclassificationOfPurchaseOptionToDerivativeLiabilities>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">15708608</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues decimals="0" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">3500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues decimals="0" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">15705108</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues decimals="INF" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares">3500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits decimals="INF" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares">2</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
  <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits xsi:nil="true" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="shares"/>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">153445</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation decimals="0" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">30</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation decimals="0" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">153415</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">119052</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation decimals="0" contextRef="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="USD">59</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation decimals="0" contextRef="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">118993</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation decimals="INF" contextRef="Context_FYE_31-Mar-2011_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares">30475</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation decimals="INF" contextRef="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_CommonStockMember" unitRef="shares">59144</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <cjjd:ProceedsFromCashInjectionContributedByShareholders decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">406546</cjjd:ProceedsFromCashInjectionContributedByShareholders>
  <cjjd:ProceedsFromCashInjectionContributedByShareholders decimals="0" contextRef="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">406546</cjjd:ProceedsFromCashInjectionContributedByShareholders>
  <cjjd:AdjustmentsToAdditionalPaidInCapitalClosingOfSubsidiary decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">-6456</cjjd:AdjustmentsToAdditionalPaidInCapitalClosingOfSubsidiary>
  <cjjd:AdjustmentsToAdditionalPaidInCapitalClosingOfSubsidiary decimals="0" contextRef="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="USD">-6456</cjjd:AdjustmentsToAdditionalPaidInCapitalClosingOfSubsidiary>
  <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">59</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
  <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination decimals="0" contextRef="Context_FYE_31-Mar-2012_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="USD">59</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>

  <us-gaap:NetIncomeLoss decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">8141626</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">8432458</us-gaap:NetIncomeLoss>
  <us-gaap:ProfitLoss decimals="0" contextRef="Context_FYE_31-Mar-2011" unitRef="USD">8432458</us-gaap:ProfitLoss>
  <us-gaap:ProfitLoss decimals="0" contextRef="Context_FYE_31-Mar-2012" unitRef="USD">8140479</us-gaap:ProfitLoss>
  <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link"/>
</xbrli:xbrl>